Pliant Therapeutics, Inc. (PLRX) Ownership

$13.18

south_east
-$0.35 (-2.59%)
Day's range
$13.02
Day's range
$13.68

Pliant Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
DEEP TRACK CAPITAL, LP 02/14/2025 5.97 M $78.65 M   0.00% 9.83%
BLACKROCK FUNDING, INC. /DE 02/07/2025 5.18 M $68.22 M   -0.75% 8.53%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 4.63 M $61.04 M   -4.14% 7.63%
FMR LLC 02/13/2025 3.88 M $51.05 M   -0.59% 6.38%
VANGUARD GROUP INC 02/11/2025 3.23 M $42.52 M   -8.44% 5.32%
PARADIGM BIOCAPITAL ADVISORS LP 02/14/2025 3.20 M $42.11 M   2.98% 5.26%
REDMILE GROUP, LLC 02/14/2025 2.90 M $38.13 M   -9.45% 4.77%
BLUE OWL CAPITAL HOLDINGS LP 02/14/2025 2.77 M $36.47 M   -7.82% 4.56%
DEUTSCHE BANK AG\ 02/14/2025 2.55 M $33.61 M   66.31% 4.20%
TRV GP IV, LLC 02/13/2025 2.13 M $28.09 M   0.00% 3.51%
POLAR CAPITAL HOLDINGS PLC 02/14/2025 2.02 M $26.54 M   0.00% 3.32%
FIRST LIGHT ASSET MANAGEMENT, LLC 02/14/2025 1.68 M $22.14 M   -34.73% 2.77%
STATE STREET CORP 02/14/2025 1.39 M $18.24 M   -1.25% 2.28%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.32 M $17.34 M   -0.13% 2.17%
SILVERARC CAPITAL MANAGEMENT, LLC 02/14/2025 1.32 M $17.33 M   100.00% 2.17%
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 1.28 M $16.87 M   0.00% 2.11%
PICTET ASSET MANAGEMENT HOLDING SA 02/12/2025 1.27 M $16.67 M   -1.07% 2.08%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 02/18/2025 1.12 M $14.76 M   100.00% 1.85%
GREAT POINT PARTNERS LLC 02/14/2025 1.06 M $13.89 M   -44.77% 1.74%
FRANKLIN RESOURCES INC 02/12/2025 1.05 M $13.77 M   0.55% 1.72%
CANDRIAM S.C.A. 02/07/2025 900,104 $11.85 M   8.03% 1.48%
LOGOS GLOBAL MANAGEMENT LP 02/14/2025 750,000 $9.88 M   100.00% 1.24%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 649,660 $8.56 M   100.00% 1.07%
UBS GROUP AG 02/14/2025 628,281 $8.27 M   172.80% 1.03%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 547,297 $7.21 M   19.98% 0.90%
CHECKPOINT CAPITAL L.P. 02/14/2025 535,494 $7.05 M   40.92% 0.88%
BESSEMER GROUP INC 02/13/2025 532,174 $7.01 M   0.00% 0.88%
GRANAHAN INVESTMENT MANAGEMENT, LLC 02/14/2025 527,147 $6.94 M   -28.60% 0.87%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 459,384 $6.05 M   0.60% 0.76%
GOLDMAN SACHS GROUP INC 02/11/2025 446,700 $5.88 M   28.58% 0.74%
FERNWOOD INVESTMENT MANAGEMENT, LLC 02/13/2025 425,424 $5.60 M   -17.09% 0.70%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 404,796 $5.33 M   5.14% 0.67%
CAPTION MANAGEMENT, LLC 02/14/2025 394,500 $5.20 M   1,215.00% 0.65%
AXA S.A. 02/14/2025 346,941 $4.57 M   -0.16% 0.57%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 02/14/2025 300,000 $3.95 M   0.00% 0.49%
SPHERA FUNDS MANAGEMENT LTD. 02/14/2025 297,362 $3.92 M   0.00% 0.49%
ARROWMARK COLORADO HOLDINGS LLC 02/14/2025 281,189 $3.70 M   0.00% 0.46%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 206,947 $2.73 M   -38.31% 0.34%
JPMORGAN CHASE & CO 02/12/2025 197,251 $2.60 M   300.82% 0.32%
JANE STREET GROUP, LLC 02/14/2025 193,700 $2.55 M   5.21% 0.32%
BANK OF NEW YORK MELLON CORP 02/04/2025 184,382 $2.43 M   -0.09% 0.30%
JANE STREET GROUP, LLC 02/14/2025 182,015 $2.40 M   -2.52% 0.30%
RICE HALL JAMES & ASSOCIATES, LLC 01/31/2025 160,522 $2.11 M   2.10% 0.26%
CAPTION MANAGEMENT, LLC 02/14/2025 142,404 $1.88 M   100.00% 0.23%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 139,574 $1.84 M   18.35% 0.23%
TWO SIGMA ADVISERS, LP 02/14/2025 135,700 $1.79 M   -14.01% 0.22%
ADAR1 CAPITAL MANAGEMENT, LLC 02/13/2025 134,798 $1.78 M   -45.23% 0.22%
ATOM INVESTORS LP 02/14/2025 130,448 $1.72 M   100.00% 0.21%
WOODLINE PARTNERS LP 02/14/2025 127,295 $1.68 M   14.00% 0.21%
RHENMAN & PARTNERS ASSET MANAGEMENT AB 02/13/2025 116,250 $1.53 M   -3.33% 0.19%

Pliant Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 185 institutional investors and hedge funds held shares of Pliant Therapeutics, Inc.. The most heavily invested institutionals were:

Deep Track Capital, LP: 5.97 M

BlackRock Funding, Inc. /DE: 5.18 M

PRICE T ROWE ASSOCIATES INC /MD/: 4.63 M

FMR LLC: 3.88 M

VANGUARD GROUP INC: 3.23 M

Paradigm Biocapital Advisors LP: 3.2 M

106.62% of Pliant Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 74.24 M shares in the last 24 months. This purchase volume represents approximately $978.50 M in transactions.